Sunshine Biopharma Binghamton University

New Post Public Reply Private Reply Replies (1) Message Board
Roger Wilco

Sunshine Biopharma & Binghamton University to Present New Data at the Upcoming American Association for Cancer Research Meeti...

Date : 03/26/2012 @ 8:30AM
Source : Business Wire
Stock : Sunshine Biopharma, Inc. (SBFM)
Quote : 0.29  0.04 (16.00%) @ 10:19AM

Sunshine Biopharma & Binghamton University to Present New Data at the Upcoming American Association for Cancer Research Meeti...

Sunshine Biopharma (OTCBB:SBFM)
Intraday Stock Chart

Today : Monday 26 March 2012

Click Here for more Sunshine Biopharma Charts.

Sunshine Biopharma, Inc. (OTCBB: SBFM), which has designed and synthesized a new compound, Adva-27a, that acts as an inhibitor of multidrug resistant breast cancer cells in vitro, today announced that it will be presenting new scientific data at the American Association for Cancer Research Meeting March 31-April 4, 2012, in Chicago, Illinois, together with its research collaborator, Binghamton University, a State University of New York.

According to the American Cancer Society, approximately 1.5 million new cases of cancer are diagnosed each year in the U.S. Of these, over 230,000 are new breast cancer cases. The American Cancer Society also reports that there are over 11 million Americans living with cancer. Of these, 2.5 million are breast cancer patients. Virtually all cancers types are either aggressive at the onset or become aggressive or multidrug resistant over time. Currently, there are little or no treatment options available for multidrug resistant breast cancer patients.

The data concerning Adva-27a, which will be presented at the Chicago meeting by the Company’s research collaborator, Dr. Susannah Gal of Binghamton University, show that Adva-27a efficiently kills multidrug resistant breast cancer cells in vitro. “If the activity of Adva-27a proves to be as remarkable in vivo, this new compound would represent a breakthrough for breast cancer patients,” said Dr. Steve N. Slilaty, CEO of Sunshine Biopharma.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Afarak Group Enhances Chrome Ore Production with Green Initiatives

Updated Category News Views 221

Afarak Group's Investment in Chrome Ore Production Afarak Group SE is making significant strides in enhancing its production of metallurgical grade chrome ore concentrate. This initiative is taking place at their Vlakpoort Mine, where a new processing plant is being commissioned to support increased production capabilities. Innovative Production Techniques The new chrome...

Continue Reading
NATSO and SIGMA Advocate for Continuation of Biodiesel Tax Credit

Updated Category News Views 187

NATSO and SIGMA Advocate for Continuation of Biodiesel Tax Credit NATSO, which represents truck stops and travel centers, alongside SIGMA, a leading fuel marketers association, is pushing Congress to seize the opportunity to extend the important biodiesel blenders' tax credit of $1 per gallon. As these organizations represent a significant portion of the retail fuel...

Continue Reading
Quantum Computing Inc. Advances Its Pioneering Chip Foundry Project

Updated Category News Views 99

Quantum Computing Inc. Sets Path for Chip Foundry Completion Quantum Computing Inc. (NASDAQ: QUBT), an innovator in quantum computing and photonics technology, is drawing closer to completing its cutting-edge quantum photonic chip foundry. This facility, situated in a tech-driven environment, aims to start operations in the near future, focusing on creating advanced...

Continue Reading
Formula E Championship Climaxes in London Showdown

Updated Category News Views 5

The Electric Action Heads to London's Unique Track Crack open a brew, because London is the battleground for the Formula E title conundrum. The 2.077-kilometre indoor-outdoor circuit, snaking through Excel London, isn't just any track—it's a contraption of twists and turns. The atmosphere’s rarified, a cocktail of elevations and finicky lighting that’ll keep the...

Continue Reading
Samsara's Upcoming Financial Results Announcement Details

Updated Category News Views 288

Samsara's Financial Results Announcement Samsara Inc. (NYSE: IOT), recognized as a leader in the Connected Operations Cloud, has revealed details regarding its upcoming financial results for the fourth quarter and fiscal year 2025. This eagerly anticipated announcement is scheduled for March 6, 2025. Stakeholders and interested parties are invited to tune in as the...

Continue Reading